Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%

Number of participants experiencing an attacka · people with colchicine‐resistant familial Mediterranean fever

Canakinumab probably leads to lower number of participants experiencing an attacka compared with placebo (moderate certainty).

1 finding from 1 review

Interventions for reducing inflammation in familial Mediterranean fever 2022 · Cochrane Headline outcomes only
RR 0.41 [0.26, 0.65]
1 study · 63 participants
Moderate